JANSSEN PHARMACEUTICAL

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 2075338
                    [Title] => Janssen clinical trials for COVID-19 vaccine set this week — DOST
                    [Summary] => Clinical trials for Janssen Pharmaceutical's candidate vaccine for the coronavirus are expected to begin any time this week, Science Secretary Fortunato de la Peña said Thursday.
                    [DatePublished] => 2021-02-04 15:43:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => https://media.philstar.com/photos/2021/02/04/jansen2020-12-2921-45-02_2021-02-04_15-32-37251_thumbnail.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 1350193
                    [Title] => FDA approves Gilead Sciences drug for 3 cancers
                    [Summary] => 
The Food and Drug Administration on Wednesday approved a new cancer drug from Gilead Sciences Inc. to treat three types of blood cancer.

                    [DatePublished] => 2014-07-25 07:01:42
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 273131
                    [Title] => Janssen introduces 1st transdermal contraceptive patch for Pinoy women
                    [Summary] => Janssen Pharmaceutical, a division of Johnson & Johnson,   introduced yesterday  the first transdermal contraceptive patch for Filipino women.


EVRA (norelgestromin/ethinyl estradiol) transdermal skin patch is the first contraceptive patch that is applied directly to the skin and provides protection for a period of one week.


It provides hormones through the skin into the bloodstream which then prevents pregnancy by suppressing ovulation.


Because of it is so thin, EVRA can be worn unnoticed under clothing.


                    [DatePublished] => 2005-04-08 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 1097285
                    [AuthorName] =>  Marianne  V.  Go
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

        )

)

abtest

Janssen clinical trials for COVID-19 vaccine set this week — DOST

February 4, 2021 - 3:43pm

Clinical trials for Janssen Pharmaceutical's candidate vaccine for the coronavirus are expected to begin any time this week,...

Headlines

FDA approves Gilead Sciences drug for 3 cancers

July 25, 2014 - 7:01am

The Food and Drug Administration on Wednesday approved a new cancer drug from Gilead Sciences Inc. to treat three types of blood cancer.

Health And Family

Janssen introduces 1st transdermal contraceptive patch for Pinoy women

By Marianne V. Go | April 8, 2005 - 12:00am

Janssen Pharmaceutical, a division of Johnson & Johnson, introduced yesterday the first transdermal contraceptive patch for Filipino women. EVRA (norelgestromin/ethinyl estradiol) transdermal skin patch is...

Business